Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glucuronic Acid SCHEMBL17233397 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL12189507 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL5974 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL6759131 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL23929292 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Mucic Acid SCHEMBL23388836 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL23929291 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Mucic Acid SCHEMBL23388833 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL2559030 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 | |
| Glucuronic Acid SCHEMBL851323 | 1.00 | PDE4A (0.46) | PDE4ATSHRCYP2C9ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250051384-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | EXTREMOCHEM, LDA. (PT) | 2025-02-13 | — | — | US | claimed |
| US-12122745-B2 | Processes for preparing aldaric, aldonic, and uronic acids | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2024-10-22 | — | — | US | claimed |
| US-12098162-B2 | Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules | EXTREMOCHEM, LDA (PT) | 2024-09-24 | — | — | US | claimed |
| US-20230028813-A1 | PROCESSES FOR PREPARING ALDARIC, ALDONIC, AND URONIC ACIDS | ARCHER DANIELS MIDLAND CO (US) | 2023-01-26 | — | — | US | claimed |
| EP-4112594-A1 | PROCESSES FOR PREPARING ALDARIC, ALDONIC, AND URONIC ACIDS | Archer-Daniels-Midland Company (US) | 2023-01-04 | — | — | EP | claimed |
| EP-3822247-B1 | PROCESSES FOR PREPARING ALDARIC, ALDONIC, AND URONIC ACIDS | ARCHER DANIELS MIDLAND CO (US) | 2022-06-08 | — | — | EP | claimed |
| US-20220033427-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | EXTREMOCHEM, LDA (PT) | 2022-02-03 | — | — | US | claimed |
| WO-2021101834-A1 | PROCESSES FOR PREPARING ALDARIC, ALDONIC, AND URONIC ACIDS | ARCHER DANIELS MIDLAND COMPANY (US) | 2021-05-27 | — | — | WO | claimed |
| EP-3822247-A1 | PROCESSES FOR PREPARING ALDARIC, ALDONIC, AND URONIC ACIDS | Archer Daniels Midland Company (US) | 2021-05-19 | — | — | EP | claimed |
| EP-3710463-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | Extremochem, Lda. (PT) | 2020-09-23 | — | — | EP | claimed |
| EP-0831767-B1 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | YU RUEY J (US) | 2004-09-22 | — | — | EP | claimed |
| EP-1009398-A4 | MOLECULAR COMPLEX AND CONTROL-RELEASE OF ALPHA HYDROXYACIDS | YU RUEY J (US) | 2004-06-23 | — | — | EP | claimed |
| US-6365137-B1 | MIXTURE OF ACID, ALCOHOL AND ENZYME INHIBITOR | COLLABORATIVE LABORATORIES, INC. | 2002-04-02 | — | — | US | claimed |
| EP-1009398-A1 | MOLECULAR COMPLEX AND CONTROL-RELEASE OF ALPHA HYDROXYACIDS | Yu, Ruey J., Dr. (US) | 2000-06-21 | — | — | EP | claimed |
| EP-0831767-A4 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | YU RUEY J (US) | 2000-05-17 | — | — | EP | claimed |
| US-5877212-A | HYDROGEN BONDING WITH COMPLEXING AGENT | YU RUEY J (US) | 1999-03-02 | — | — | US | claimed |
| WO-1998046217-A1 | MOLECULAR COMPLEX AND CONTROL-RELEASE OF ALPHA HYDROXYACIDS | YU RUEY J (US) | 1998-10-22 | — | — | WO | claimed |
| EP-0831767-A1 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | Yu, Ruey J., Dr. (US) | 1998-04-01 | — | — | EP | claimed |
| US-5686489-A | TOPICALLY APPLIED TO INDUCE GLYCOSAMINOGLYCAN, PROTEOGLYCAN, COLLAGEN AND ELASTIN BIOSYNTHESIS; WRINKLE RESISTANCE | TRISTRATA TECHNOLOGY, INC. (US) | 1997-11-11 | — | — | US | claimed |
| WO-1996040047-A1 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | YU RUEY J (US) | 1996-12-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12098162-B2 | Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules | FUT6, GUSB, UGGT1 | PDE4A 3550/4885TSHR 1295/4885CYP2C9 941/4885 |
| US-20230028813-A1 | PROCESSES FOR PREPARING ALDARIC, ALDONIC, AND URONIC ACIDS | ALDOA, AKR1C4, ADSL | PDE4A 3856/4885TSHR 4053/4885CYP2C9 583/4885 |
| US-12122745-B2 | Processes for preparing aldaric, aldonic, and uronic acids | ALDOA, AKR1C4, ADSL | PDE4A 3856/4885TSHR 4053/4885CYP2C9 583/4885 |
| US-20250051384-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | FUT6, GUSB, UGGT1 | PDE4A 3550/4885TSHR 1295/4885CYP2C9 941/4885 |
| US-20220033427-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | FUT6, GUSB, UGGT1 | PDE4A 3550/4885TSHR 1295/4885CYP2C9 941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.